Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins

Clinical Endocrinology

Volumn 48, Issue 2, 1998, Pages 187-194

  Tan, K C B ^a,b   Shiu, S W M ^a   Pang, R W C ^b   Kung, A W C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b QUEEN MARY HOSPITAL   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE ENANTATE; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CLINICAL ARTICLE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME REGULATION; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; INTRAMUSCULAR DRUG ADMINISTRATION; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031887049     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1998.3721211.x     Document Type: Article

References (41)

1. Anderson, R.A., Wallace, E.M. & Wu, F.C. (1995) Effect of testosterone enanthate on serum lipoproteins in man. Contraception, 52, 115-119.
2. 2 cholesterol. Metabolism, 43, 935-939.
3. Bagatell, C.J., Knopp, R.H., Vale, W.W., Rivier, J.E. & Bremner, W.J. (1992) Physiologic testosterone levels in normal men suppress high-density lipoprotein levels. Annals of Internal Medicine, 116, 967-973.
4. Barrett-Connor, E. & Khaw, K.T. (1988) Endogenous sex hormones and cardiovascular disease in men. Circulation, 78, 539-545.
5. Brinton, E.A., Eisenberg, S. & Breslow, J.L. (1994) Human HDL cholesterol levels are determined by apo A-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Arteriosclerosis and Thrombosis, 14, 707-720.
6. Busch, S.J., Barnhart, R.L., Martin, G.A., Fitzgerald, M.C., Yates, M.T., Mao, S.J., Thomas, C.E. & Jackson, S.J. (1994) Human hepatic triglyceride expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. Journal of Biological Chemistry, 269, 16376-16382.
7. Clay, M.A., Newham, H.H., Forte, T.M. & Barter, P.J. (1992) Cholesteryl ester transfer protein and hepatic lipase activity promote shedding of apo A-I from HDL and subsequent formation of discoidal HDL. Biochemica Biophysica Acta, 1124, 52-58.
8. Crook, D. & Seed, M. (1990) Endocrine control of plasma lipoprotein metabolism: effects of gonadal steroids. Baillière's Clinical Endocrinology and Metabolism, 4, 851-876.
9. Eckel, R.H., Goldberg, I.J., Steiner, L., Yost, T.J. & Paterniti, J.R. (1988) Plasma lipolytic activity. Relationship to postheparin lipolytic activity and evidence for metabolic regulation. Diabetes, 37, 610-615.
10. Ehnholm, C. & Kuusi, T. (1986) Preparation, characterisation, and measurement of hepatic lipase. Methods in Enzymology, 129, 716-738.
11. Fan, J., Wang, J., Bensadoun, A., Lauer, S.J., Dang, Q., Mahley, R.W. & Taylor, J.M. (1994) Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proceedings of the National Academy of Science USA, 91, 8724-8728.
12. Friedl, K.E., Hannan, C.J., Jones, R.E. & Plymate, S.R. (1990) High-density lipoprotein cholesterol is not decreased if an aromatisable androgen is administered. Metabolism. 39, 69-74.
13. Fruchart, J.C. & Ailhaud, G. (1992) Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. Clinical Chemistry. 38, 793-797.
14. Furman, R.H., Howard, R.P., Norcia, L.N. & Keaty, E.C. (1958) The influence of androgens, estrogens and related steroids on serum lipids and lipoproteins. American Journal of Medicine. 24, 80-97.
15. Genest, J.J. Jr, Bard, J.M., Fruchart, J.C., Ordovas, J.M., Wilson, P.F., Schaefer, E.J. (1991) Plasma apolipoprotein A-I, A-II, B. E and C-III containing in men with premature coronary artery disease. Atherosclerosis, 90, 149-157.
16. Haffner, S.M., Kushwaha, R.S., Foster, D.M., Applebaum-Bowden, D. & Hazzard, W.R. (1983) Studies on the metabolic mechanism of reduced high density lipoproteins during anabolic steroid therapy. Metabolism. 32, 413-420.
17. Haffner, S.M., Mykkanen, L., Valdez, R.A. & Katz, M.S. (1993) Relation of sex hormones to lipids and lipoproteins in non-diabetic men. Journal of Clinical Endocrinology and Metabolism, 77, 1610-1615.
18. Handelsman, D.J., Conway, A.J., Howe, C.J., Turner, L. & Mackey, M.A. (1996) Establishing the minimum effective dose and additive effects of depot progestin on suppression of human spermatogenesis by a testosterone depot. Journal of Clinical Endocrinology and Metabolism, 81, 4113-4121.
19. Jones, D.B., Higgins, B., Billet, J.S., Price, W.H., Edwards, C.R.W., Beastall, G.H., Shepherd, J., Sweeting, V.M., Horn, D.B. & Wenham, P.R. (1989) The effect of testosterone replacement on plasma lipids and apolipoproteins. European Journal of Clinical Investigation, 19, 438-441.
20. Kelley, J.L. & Kruski, A.W. (1986) Density gradient ultracentrifugation of serum lipoproteins in a swinging bucket rotor. Methods in Enzymology, 128, 170-181.
21. Lichtenstein, M.J., Yarnell, J.W.G., Elwood, P.C., Beswick, A.D., Sweetnam, P.M., Marks, V., Teale, D. & Riad Fahmy, D. (1987) Sex hormones, insulin, lipids, and prevalent ischaemic heart disease American Journal of Epidemiology, 126, 647-657.
22. Meriggiola, M.C., Marcovina, S., Paulsen, C.A. & Bremner, W.J. (1995) Testosterone enanthate at a dose of 200 mg/week decreases HDL-cholesterol levels in healthy men. International Journal of Andrology, 18, 237-242.
23. Morley, J.E., Perry, H.M., Kaiser, F.E., Kraenzle, D., Jensen, J., Houston, K., Mattammal, M. & Perry, H.M. Jr (1993) Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. Journal of the American Geriatrics Society, 41, 149-152.
24. Oppenheim, D.S., Greenspan, S.L., Zervas, N.T., Schoenfeld, D.A. & Klibanski, A. (1989) Elevated serum lipids in hypogonadal men with and without hyperprolactinemia. Annals of Internal Medicine, 111, 288-292.
25. Ozata, M., Yildirimkaya, M., Bulur, M., Yilmaz, K., Bolu, E., Corakci, A. & Gundogan, M.A. (1996) Effects of gonadotropin and testosterone treatments on lipoprotein (a), high density lipoprotein particles, and other lipoprotein levels in male hypogonadism. Journal of Clinical Endocrinology and Metabolism, 81, 3372-3378.
26. Pavlou, S.N., Brewer, K., Farley, M.G., Lindner, J., Bastias, M.C., Rogers, B.J., Swift, L.L., River, J.E., Vale, W.W., Conn, P.M. & Herbert, C.M. (1991) Combined administration of a gonadotrophin-releasing hormone antagonist and testosterone in men induces reversible azoopsermia without loss of libido. Journal of Clinical Endocrinology and Metabolism, 73, 1360-1369.
27. Phillips, G.B., Pinkernell, B.H. & Jing, T.Y. (1994) The association of hypotestosteronemia with coronary artery disease in men. Arteriosclerosis and Thrombosis, 14, 701-706.
28. Plump, A.S., Scott, C.J. & Breslow, J.L. (1994) Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proceedings of the National Academy of Science USA, 91, 9607-9611.
29. Schultz, J.R., Verstuyft, J.G., Gong, E.L., Nichols, A.V. & Rubin, E.M. (1993) Protein composition determines the anti-atherogenic properties of HDL in transgenic mice. Nature, 365, 762-764.
30. Silliman, K., Tall, A.R., Kretchmer, N. & Forte, T.M. (1993) Unusual high-density lipoprotein subclass distribution during late pregnancy. Metabolism, 12, 1592-1599.
31. Snyder, P.J. & Lawrence, D.A. (1980) Treatment of male hypogonadism with testosterone enanthate. Journal of Clinical Endocrinology and Metabolism, 51, 1335-1339.
32. Sorva, R., Kussi, T., Taskinen, M.R., Perheentupa, J. & Nikkila, E.A. (1988) Testosterone substitution increases the activity of lipoprotein lipase and hepatic lipase in hypogonadal males. Atherosclerosis, 69, 191-197.
33. Tall, A.R. (1993) Plasma cholesteryl ester transfer protein. Journal of Lipid Research, 34, 1255-1274.
34. Tan, K.C.B., Shiu, S.W.M., Janus, E.D. & Lam, K.S.L., (1997) LDL subtractions in acromegaly: relation to growth hormone and insulin-like growth factor-I. Atherosclerosis, 129, 59-65.
35. Thompson, P.D., Cullinane, E.M., Sady, S.P., Chenevert, C., Saritelli, A.L., Sady, M.A. & Herbert, P.N. (1989) Contrasting effects of testosterone and stanozolol on serum lipoprotein levels. Journal of the American Medical Association. 261, 1165-1168.
36. Valdemarsson, S., Hedner, P. & Nilsson-Ehle, P. (1987) Increase in hepatic lipase activity after testosterone substitution in men with hypogonadism of pituitary origin. Acta Media Scandinavica, 221, 363-366.
37. Wang, J., Thornton, J.C., Russell, M., Burastero, S., Heymsfield, S. & Pierson, R.N. Jr (1994) Asians have lower body mass index hut higher percent body fat than do whites: comparisons of anthropometric measurements. American Journal of Clinical Nutrition, 60, 23-28.
38. WHO Task Force on methods for the regulation of male fertility (1990) Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet, 336, 955-959.
39. WHO Task Force on methods for the regulation of male fertility (1996) Contraceptive efficacy of testosterone-induced azoospermia and oligospermia in normal men. Fertility and Sterility, 65, 821-829.
40. Zgliczynski, S., Ossowski, M., Slowinska-Srzednicka, J., Brzezinska, A., Zgliczynski, W., Soszynski, P., Chotkowska, E., Srzednicki, M. & Sadowski, Z. (1996) Effects of testosterone replacement therapy on lipids and lipoproteins in hypogonadal and elderly men. Atherosclerosis, 121, 35-43.
41. Zmuda, J.M., Fahrenbach, M.C., Younkin, B.T., Bausserman, L.L., Terry, R.B., Catlin, D.H. & Thompson, P.D. (1993) The effect of testosterone aromatization on high density lipoprotein cholesterol level and postheparin lipolytic activity. Metabolism, 42, 446-450.